Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-herpesvirus Agent Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Amenamevir
1.2.3 Famciclovir
1.3 Market by Application
1.3.1 Global Anti-herpesvirus Agent Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Medical Field
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-herpesvirus Agent Market Perspective (2024-2034)
2.2 Anti-herpesvirus Agent Growth Trends by Region
2.2.1 Global Anti-herpesvirus Agent Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Anti-herpesvirus Agent Historic Market Size by Region (2024-2024)
2.2.3 Anti-herpesvirus Agent Forecasted Market Size by Region (2024-2034)
2.3 Anti-herpesvirus Agent Market Dynamics
2.3.1 Anti-herpesvirus Agent Industry Trends
2.3.2 Anti-herpesvirus Agent Market Drivers
2.3.3 Anti-herpesvirus Agent Market Challenges
2.3.4 Anti-herpesvirus Agent Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-herpesvirus Agent Players by Revenue
3.1.1 Global Top Anti-herpesvirus Agent Players by Revenue (2024-2024)
3.1.2 Global Anti-herpesvirus Agent Revenue Market Share by Players (2024-2024)
3.2 Global Anti-herpesvirus Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-herpesvirus Agent Revenue
3.4 Global Anti-herpesvirus Agent Market Concentration Ratio
3.4.1 Global Anti-herpesvirus Agent Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-herpesvirus Agent Revenue in 2022
3.5 Anti-herpesvirus Agent Key Players Head office and Area Served
3.6 Key Players Anti-herpesvirus Agent Product Solution and Service
3.7 Date of Enter into Anti-herpesvirus Agent Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-herpesvirus Agent Breakdown Data by Type
4.1 Global Anti-herpesvirus Agent Historic Market Size by Type (2024-2024)
4.2 Global Anti-herpesvirus Agent Forecasted Market Size by Type (2024-2034)
5 Anti-herpesvirus Agent Breakdown Data by Application
5.1 Global Anti-herpesvirus Agent Historic Market Size by Application (2024-2024)
5.2 Global Anti-herpesvirus Agent Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Anti-herpesvirus Agent Market Size (2024-2034)
6.2 North America Anti-herpesvirus Agent Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Anti-herpesvirus Agent Market Size by Country (2024-2024)
6.4 North America Anti-herpesvirus Agent Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-herpesvirus Agent Market Size (2024-2034)
7.2 Europe Anti-herpesvirus Agent Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Anti-herpesvirus Agent Market Size by Country (2024-2024)
7.4 Europe Anti-herpesvirus Agent Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-herpesvirus Agent Market Size (2024-2034)
8.2 Asia-Pacific Anti-herpesvirus Agent Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Anti-herpesvirus Agent Market Size by Region (2024-2024)
8.4 Asia-Pacific Anti-herpesvirus Agent Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-herpesvirus Agent Market Size (2024-2034)
9.2 Latin America Anti-herpesvirus Agent Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Anti-herpesvirus Agent Market Size by Country (2024-2024)
9.4 Latin America Anti-herpesvirus Agent Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-herpesvirus Agent Market Size (2024-2034)
10.2 Middle East & Africa Anti-herpesvirus Agent Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Anti-herpesvirus Agent Market Size by Country (2024-2024)
10.4 Middle East & Africa Anti-herpesvirus Agent Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Asahi Kasei Corporation
11.1.1 Asahi Kasei Corporation Company Detail
11.1.2 Asahi Kasei Corporation Business Overview
11.1.3 Asahi Kasei Corporation Anti-herpesvirus Agent Introduction
11.1.4 Asahi Kasei Corporation Revenue in Anti-herpesvirus Agent Business (2024-2024)
11.1.5 Asahi Kasei Corporation Recent Development
11.2 Maruho Co., Ltd.
11.2.1 Maruho Co., Ltd. Company Detail
11.2.2 Maruho Co., Ltd. Business Overview
11.2.3 Maruho Co., Ltd. Anti-herpesvirus Agent Introduction
11.2.4 Maruho Co., Ltd. Revenue in Anti-herpesvirus Agent Business (2024-2024)
11.2.5 Maruho Co., Ltd. Recent Development
11.3 AiCuris
11.3.1 AiCuris Company Detail
11.3.2 AiCuris Business Overview
11.3.3 AiCuris Anti-herpesvirus Agent Introduction
11.3.4 AiCuris Revenue in Anti-herpesvirus Agent Business (2024-2024)
11.3.5 AiCuris Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-herpesvirus Agent Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Amenamevir
Table 3. Key Players of Famciclovir
Table 4. Global Anti-herpesvirus Agent Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 5. Global Anti-herpesvirus Agent Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Anti-herpesvirus Agent Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Anti-herpesvirus Agent Market Share by Region (2024-2024)
Table 8. Global Anti-herpesvirus Agent Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Anti-herpesvirus Agent Market Share by Region (2024-2034)
Table 10. Anti-herpesvirus Agent Market Trends
Table 11. Anti-herpesvirus Agent Market Drivers
Table 12. Anti-herpesvirus Agent Market Challenges
Table 13. Anti-herpesvirus Agent Market Restraints
Table 14. Global Anti-herpesvirus Agent Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Anti-herpesvirus Agent Market Share by Players (2024-2024)
Table 16. Global Top Anti-herpesvirus Agent Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-herpesvirus Agent as of 2022)
Table 17. Ranking of Global Top Anti-herpesvirus Agent Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Anti-herpesvirus Agent Revenue (CR5 and HHI) & (2024-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-herpesvirus Agent Product Solution and Service
Table 21. Date of Enter into Anti-herpesvirus Agent Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-herpesvirus Agent Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Anti-herpesvirus Agent Revenue Market Share by Type (2024-2024)
Table 25. Global Anti-herpesvirus Agent Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Anti-herpesvirus Agent Revenue Market Share by Type (2024-2034)
Table 27. Global Anti-herpesvirus Agent Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Anti-herpesvirus Agent Revenue Market Share by Application (2024-2024)
Table 29. Global Anti-herpesvirus Agent Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Anti-herpesvirus Agent Revenue Market Share by Application (2024-2034)
Table 31. North America Anti-herpesvirus Agent Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 32. North America Anti-herpesvirus Agent Market Size by Country (2024-2024) & (US$ Million)
Table 33. North America Anti-herpesvirus Agent Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Anti-herpesvirus Agent Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. Europe Anti-herpesvirus Agent Market Size by Country (2024-2024) & (US$ Million)
Table 36. Europe Anti-herpesvirus Agent Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Anti-herpesvirus Agent Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Asia-Pacific Anti-herpesvirus Agent Market Size by Region (2024-2024) & (US$ Million)
Table 39. Asia-Pacific Anti-herpesvirus Agent Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Anti-herpesvirus Agent Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 41. Latin America Anti-herpesvirus Agent Market Size by Country (2024-2024) & (US$ Million)
Table 42. Latin America Anti-herpesvirus Agent Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Anti-herpesvirus Agent Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Middle East & Africa Anti-herpesvirus Agent Market Size by Country (2024-2024) & (US$ Million)
Table 45. Middle East & Africa Anti-herpesvirus Agent Market Size by Country (2024-2034) & (US$ Million)
Table 46. Asahi Kasei Corporation Company Detail
Table 47. Asahi Kasei Corporation Business Overview
Table 48. Asahi Kasei Corporation Anti-herpesvirus Agent Product
Table 49. Asahi Kasei Corporation Revenue in Anti-herpesvirus Agent Business (2024-2024) & (US$ Million)
Table 50. Asahi Kasei Corporation Recent Development
Table 51. Maruho Co., Ltd. Company Detail
Table 52. Maruho Co., Ltd. Business Overview
Table 53. Maruho Co., Ltd. Anti-herpesvirus Agent Product
Table 54. Maruho Co., Ltd. Revenue in Anti-herpesvirus Agent Business (2024-2024) & (US$ Million)
Table 55. Maruho Co., Ltd. Recent Development
Table 56. AiCuris Company Detail
Table 57. AiCuris Business Overview
Table 58. AiCuris Anti-herpesvirus Agent Product
Table 59. AiCuris Revenue in Anti-herpesvirus Agent Business (2024-2024) & (US$ Million)
Table 60. AiCuris Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-herpesvirus Agent Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Anti-herpesvirus Agent Market Share by Type: 2022 VS 2034
Figure 3. Amenamevir Features
Figure 4. Famciclovir Features
Figure 5. Global Anti-herpesvirus Agent Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Anti-herpesvirus Agent Market Share by Application: 2022 VS 2034
Figure 7. Medical Field Case Studies
Figure 8. Other Case Studies
Figure 9. Anti-herpesvirus Agent Report Years Considered
Figure 10. Global Anti-herpesvirus Agent Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 11. Global Anti-herpesvirus Agent Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Anti-herpesvirus Agent Market Share by Region: 2022 VS 2034
Figure 13. Global Anti-herpesvirus Agent Market Share by Players in 2022
Figure 14. Global Top Anti-herpesvirus Agent Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-herpesvirus Agent as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Anti-herpesvirus Agent Revenue in 2022
Figure 16. North America Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 17. North America Anti-herpesvirus Agent Market Share by Country (2024-2034)
Figure 18. United States Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 19. Canada Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. Europe Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Europe Anti-herpesvirus Agent Market Share by Country (2024-2034)
Figure 22. Germany Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. France Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. U.K. Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. Italy Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Russia Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Nordic Countries Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Asia-Pacific Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Asia-Pacific Anti-herpesvirus Agent Market Share by Region (2024-2034)
Figure 30. China Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Japan Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. South Korea Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Southeast Asia Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. India Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Australia Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Latin America Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Latin America Anti-herpesvirus Agent Market Share by Country (2024-2034)
Figure 38. Mexico Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Brazil Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Middle East & Africa Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Middle East & Africa Anti-herpesvirus Agent Market Share by Country (2024-2034)
Figure 42. Turkey Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Saudi Arabia Anti-herpesvirus Agent Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Asahi Kasei Corporation Revenue Growth Rate in Anti-herpesvirus Agent Business (2024-2024)
Figure 45. Maruho Co., Ltd. Revenue Growth Rate in Anti-herpesvirus Agent Business (2024-2024)
Figure 46. AiCuris Revenue Growth Rate in Anti-herpesvirus Agent Business (2024-2024)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed